Table III.
Cell viability of transfected NPC cell lines.
| Survival fraction (%) | ||||
|---|---|---|---|---|
| Radiation doses (Gy) | miR-495 mimics-5-8F-IR | NC-5-8F-IR | miR-495 inhibitors-5-8F | NC-5-8F |
| 2 | 92±2.0 | 96±2.2 | 97±2.0 | 95±1.8 |
| 4 | 76±3.0 | 88±3.0 | 90±2.8 | 82±2.8 |
| 6 | 58±2.8 | 78±3.1 | 82±3.2 | 68±3.0 |
| 8 | 36±2.6 | 68±2.4 | 72±2.6 | 52±3.1 |
| 10 | 16±2.8 | 54±2.5 | 60±3.1 | 36±3.0 |
| aRPF | RPF1=1.04; P<0.05 | RPF2=1.02; P<0.05 | ||
a
RPF1 is the RPF of miR-495 mimics-5-8F-IR; RPF2 is the RPF of miR-495 inhibitors-5-8F. NPC, nasopharyngeal carcinoma. NC, negative control; IR, radioresistance.